Sunday, April 02, 2017 9:54:56 PM
Thx, math has been verified
SequestOx™ projected revenues just from ER docs and dentist
Quote:
40,000 ER docs in the U.S. with at least as many NP/PA's working in the ED, probably a lot more. Approx 80,000 E.R. providers.
Now add in Urgent Care. 10,000 urgent care clinics in the U.S. Each clinic probably has an average four docs and as many NP/PA's, so we'll approximate another 80,000 urgent care providers.
Approximately 160,000 E.R. and urgent care providers in the U.S.. We convince just 10% to switch to SequestOx™, and they write an average of one script per shift- about 20 scripts in a month of 20 pills each.
160,000 x 10% = 16,000
16,000 x 20 scripts x 20 pills x 12 months = 76,800,000 capsules per year.
Now set your price
. Say $5/capsule (approx. 5x of generic oxy capsules).
76,800,000 capsules x $5/cap = $384,000,000 / year in revenue just from 10% of ER and urgent care providers writing 1 SequestOx #20 script per shift.
Now what happens if you get buy-in from 25% of the those providers? 50%? Now start to add in pain management, primary care, and orthopedics.
Above was WeeZuhls post
--------------
Now add in the Dentist :
146,800 Dentist x10% = 14680 (10% of dds) x 20 scrips x 20 pills x 12 months x $5/capsule is an additional:
70,464,000 x $5 dollars + my calculator only has 8 digits and its starting to smoke.
An additional $353+ million in revenues from 10% od dentist RXing SequestOx™.
Now add this to Weezhuls 10% of ER Drs $384 million
For a grand total of $736 million in revenues.
Now we have 15 more ADFs to add to it.
Trying to keep it conservative it could be multiples higher
ELTP
SequestOx™ projected revenues just from ER docs and dentist
Quote:
40,000 ER docs in the U.S. with at least as many NP/PA's working in the ED, probably a lot more. Approx 80,000 E.R. providers.
Now add in Urgent Care. 10,000 urgent care clinics in the U.S. Each clinic probably has an average four docs and as many NP/PA's, so we'll approximate another 80,000 urgent care providers.
Approximately 160,000 E.R. and urgent care providers in the U.S.. We convince just 10% to switch to SequestOx™, and they write an average of one script per shift- about 20 scripts in a month of 20 pills each.
160,000 x 10% = 16,000
16,000 x 20 scripts x 20 pills x 12 months = 76,800,000 capsules per year.
Now set your price
. Say $5/capsule (approx. 5x of generic oxy capsules).
76,800,000 capsules x $5/cap = $384,000,000 / year in revenue just from 10% of ER and urgent care providers writing 1 SequestOx #20 script per shift.
Now what happens if you get buy-in from 25% of the those providers? 50%? Now start to add in pain management, primary care, and orthopedics.
Above was WeeZuhls post
--------------
Now add in the Dentist :
146,800 Dentist x10% = 14680 (10% of dds) x 20 scrips x 20 pills x 12 months x $5/capsule is an additional:
70,464,000 x $5 dollars + my calculator only has 8 digits and its starting to smoke.
An additional $353+ million in revenues from 10% od dentist RXing SequestOx™.
Now add this to Weezhuls 10% of ER Drs $384 million
For a grand total of $736 million in revenues.
Now we have 15 more ADFs to add to it.
Trying to keep it conservative it could be multiples higher
ELTP
You Can Tell A Man's Character By The Way He Treats Those Who Can Do Nothing For Him
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
